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Mast cells have been demonstrated in increased numbers in certain neoplasms in 
humans  (1-3)  and  in  both spontaneous tumors and  those induced  by carcinogenic 
agents  in  animals  (4,  5).  Eosinophils  are often closely associated with  mast cells in 
inflammatory reactions, and these cells also are present in increased numbers in some 
neoplasms (6). The role of these inflammatory cells in the host defense against tumors 
is unknown. 
A number of distinct peroxidases exist in mammalian tissues which differ in primary 
structure  and  in  their  heme  prosthetic  group.  When  combined  with  H202  and  a 
halide, peroxidases are toxic to a variety of targets including tumor cells. Peroxidases 
shown to have tumoricidal activity in vitro include the milk peroxidase (lactoperoxi- 
dase)  (7), the neutrophil  (and monocyte) peroxidase  (myeloperoxidase)  (8), and the 
eosinophil peroxidase (EPO) x (9).  Mast cell granules (MCG) contain a small amount 
of peroxidase  activity  (10),  and  this  activity is considerably  increased  by the  firm 
binding of the positively charged EPO to the surface of the negatively charged MCG 
(11).  H202 at relatively high concentrations can induce mast cell degranulation  (12, 
13). When the H202 concentration is lowered to a  level where it is ineffective alone, 
noncytotoxic mast cell secretion is initiated on the supplementation of the H202 with 
EPO and a  halide  (14).  We report here that mast cells are toxic to a  line of mouse 
aseites lymphoma cells when combined with H202 and a  halide. The H202 initiates 
mast cell secretion; the released granules with their endogenous peroxidase are toxic 
to the tumor cells in the presence of H202 and a  halide.  In addition,  the binding of 
EPO to the MCG greatly potentiates their tumoricidal activity. 
Materials and Methods 
Special Reagents.  Compound 48/80, guaiacol (anhydrous),  and Triton X-100 were obtained 
from Sigma Chemical Co., St. Louis, Mo.; glutaraldehyde from Polysciences, Inc., Warrington, 
Pa.;  osmium  tetroxide from Scientific Chemical Co.,  Huntington  Beach, Calif.; and  sodium 
chloride (Suprapur)  was obtained from Matheson Coleman and Bell, Norwood, Ohio. All other 
reagents were of the highest  commercial grade available. EPO was partially purified  from 
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guinea pig peritoneal eosinophils and assayed by guaiacol oxidation as previously described 
(15). 
Target Cells.  A Maloney virus-induced ascites lymphoma cell line, designated LSTRA, was 
maintained by serial intraperitoneal passage in BALB/c mice. After harvesting by peritoneal 
lavage,  the  cells  were  processed  and  labeled  with  5~Cr (Na251CrO4, 100-300  #Ci//~g  Cr, 
Amersham/Searle Corp., Arlington Heights, Ill.) as previously described (9). Final cell suspen- 
sions contained 2 X 10n/ml viable 51Cr-labeled LSTRA in 0.1 M sodium sulfate for experiments 
with  MCG,  MCG-EPO  complexes,  and  free  EPO,  and  in  0.154  M  sodium  chloride  for 
experiments with intact mast cells. 
Isolation of Mast CeUs.  Mast cells were obtained from the peritoneal cavities of male Sprague- 
Dawley rats and purified by using a 38% bovine serum albumin density gradient as previously 
described (14). The cell suspensions contained >90% mast cells (<10% mononuclear cells and 
<1% eosinophils) as determined by toluidine blue staining. The mast cells were always >95% 
viable as measured by trypan blue exclusion (16). 
Preparation of MCG  and  MCG-EPO  Complexes.  Membrane-free  MCG  were  obtained  by 
osmotic lysis of purified mast cells followed by differential centrifugation (14). The MCG were 
washed twice in 0.1 M phosphate buffer, pH 7.0, to remove histamine and other loosely bound 
mediators. For preparation of MCG-EPO complexes, EPO was incubated with histamine-free 
MCG  as previously described (11).  The  complexes were  washed  three  times, suspended  in 
water, and assayed for peroxidase activity by guaiacol oxidation. 
Cytotoxicity Assay.  The components of the reaction mixture (see legends to figures and tables) 
were incubated in  10- ×  75-ram glass tubes for 60 rain at 37°C. Cytotoxicity was determined 
by the SlCr-release assay as previously described (9). 51Cr release was expressed as a percentage 
of the maximum releasable activity seen in supernatant fluids of cells treated with  1% Triton 
X-100. 
Measurement of Histamine and Lactate Dehydrogenase (LDH) Release.  Mast cells were preincu- 
bated for 5  min  at  37°C  in a  water bath oscillating 80 times/min. The components of the 
reaction mixture (see legend to Table I) were added to a total volume of 0.5 ml with the H2Oz 
added last to start the reaction. After 1 h incubation at 37°C, the suspensions were placed on 
ice and histamine and LDH release was measured as previously described (14). 
Electron Microscopic Studies.  Pellets of 2  ×  l0  s mast cells incubated with 2  ×  105 LSTRA 
tumor cells and the various components of the reaction mixture (see legends to figures) were 
collected by centrifugation at  400  g  and  prepared  for  transmission electron  microscopy as 
previously described (14). The samples were examined with a JEOL  100B electron microscope 
(JEOL USA, Electron Optics Div., Medford, Mass.) at 60 kV. 
The mast cell (or MCG)-tumor cell preparations (see legends to figures) were prepared for 
scanning  electron  microscopy by  fixation  in  2%  glutaraldehyde  followed  by  1%  osmium 
tetroxide. The samples then underwent ethanol dehydration, critical-point drying with liquid 
CO2, and  sputter coating with a  gold/palladium mixture before examination with a JEOL 
JSM-35c scanning electron microscope at  19 kV. 
Statistical Analysis.  The data are reported as the mean :tz SE of the combined experiments. 
Differences were analyzed for significance using Student's two-tailed t  test  for independent 
means (not significant, P >  0.05). 
Results 
Mast  Cell-mediated  Tumoricidal  Activity.  Incubation  of 51Cr-labeled LSTRA  tumor 
cells for 60 min at pH 7.0 with intact mast cells, H202 (10  -4 M), and iodide (10 -4 M), 
increased  nlCr  release  from  a  background  of  18.8  to  41.2%  (P <  0.01)  under  the 
conditions used in Table I. The mast  (effector) to tumor (target) cell ratio was  10:1. 
Toxicity to the tumor cells as measured by 51Cr release was abolished by omission of 
iodide, H~O2,  or mast  cells, or by the addition of the hemeprotein  inhibitors azide 
and  aminotriazole.  Cyanide  at  10 -3  M  did  not  significantly inhibit  the  cytotoxic 
activity of the  intact  mast  cell  system.  When  iodide and  H202  were  replaced  by 522  MAST CELL-MEDIATED TUMOR-CELL KILLING 
TABLE  I 
Cytotoxic Activity  of Mast Cells or Mast Cell Granules* 
Supplements 
61Cr release 
Mast cells  MCG 
%  P  %  P 
Background  18.8 ±  1.5 (4):1:  19.9 ±  2.1  (6) 
Mast cells or MCG +  iodide +  H202  41.2 +  5.6 (4)  <0.01  61.9 ±  7.5 (6)  <0.001 
Iodide omitted  18.5 +  3.1 (4)  20.5 ±  2.0 (6) 
H~O2 omitted  20.3 ±  2.9 (4)  21.9 ±  1.5 (6) 
Mast cells omitted  19.1 ±  2.5 (4) 
MCG omitted  20.8 ±  2.5 (6) 
MCG heated  22.7 ±  3.5 (3) 
Azide added  20.7 ±  3.4 (3)  21.4 ±  3.4 (4) 
Cyanide added  36.1 ±  2.8 (3)  <0.01  30.2 ±  3,1 (4)  <0.05 
Aminotriazole added  17.6 ±  2.7 (3)  22.1 ±  2.8 (4) 
Mast cells + compound 48/80  23.4 ±  2.1 (4) 
* The standard salt solution  for the mast cells system consisted of 5 X 10  -a M sodium phosphate buffer, pH 
7.0,  1.2 ×  10 -2 M  KC1, 0.11 M  NaCI,  2 ×  10  -3 M MgC12, and  10  -3 M  CaCI2 and that  for the MCG 
system  was 3 X  10 -~ M sodium phosphate buffer,  pH 7.0, 1.5 ×  10  -3 M  KH2PO4, and  1.5 ×  10 -3 M 
MgSO4. The reaction mixture contained, in addition,  10  s LSTRA cells (mean 18,500 cpm 61Cr), 0.005% 
gelatin, and the supplements where indicated as follows: mast cells, 1 ×  106; MCG, 8 gg containing 0.15- 
0.2 mU peroxidase  activity; sodium iodide,  10  -4 M; H202,  10  -4 M; sodium azide 10  -3 M for mast  cell 
system and 10  -4 M for MCG systems; sodium cyanide, 10  -3 M; aminotriazole, 10  -2 M; compound 48/80, 
1 #g/ml.  The  MCG were heated  at  100°C  for  15  min  where  indicated.  Probability  values  for  the 
difference  from background are shown where significant  (P <  0.05). 
$ Mean ±  SE of experiments (n). 
compound  48/80, an agent which stimulates mast cell secretion, no significant toxicity 
to the tumor cells was observed. 
The  toxicity  to  tumor  cells  of  mast  cells,  H202,  and  iodide  was  confirmed  by 
transmission  and  scanning  electron  microscopy.  Greater  than  90%  of  mast  cells 
incubated  with  tumor  cells  in  the  standard  salt  solution  alone  exhibited  the  usual 
morphology  of normal  cells  with  numerous  electron-dense  membrane-bound  cyto- 
plasmic  granules  (Fig.  1)  and  characteristic  surface  projections  (Fig.  1;  Fig.  4).  The 
LSTRA  tumor  cells  also  exhibited  their  usual  morphology  under  these  conditions 
(Fig.  1;  Fig. 4).  They  are smaller than  mast  cells and  contain  a  single large nucleus, 
the usual array of cytoplasmic organelles (e.g., mitochondria,  endoplasmic reticulum, 
Golgi vesicles), and  lipidlike cytoplasmic  inclusions  (Fig.  1).  Numerous  short  villous 
projections are seen on the tumor cell surface  (Fig.  1;  Fig. 4). 
When  compound  48/80 was added to the mast cell-tumor cell suspension,  mast cell 
degranulation  was  evident  morphologically  (Fig.  2;  Fig.  5).  Many  swollen  and  less 
dense  granules  were seen  in  intracellular  vacuoles and  channels  (Fig.  2),  and  others 
were seen  in  the extracellular space  and  on  the surface of adjacent  tumor  cells  (Fig. 
5).  There was  no evidence of cytotoxic damage  to either the mast  cells or the tumor 
cells. 
When  mast  cells  were  incubated  with  tumor  cells  in  the  presence  of H202  and 
iodide,  mast  cell  morphology  was  similar  to  that  of cells  treated  with  compound 
48/80;  that  is, noncytotoxic degranulation  was observed (Fig. 3a; Fig. 6). However, in 
contrast  to the findings with compound  48/80, when H202 and iodide were employed 
the  tumor  cells  showed  marked  cytotoxic  changes  (Fig.  3;  Fig.  6).  Transmission Ftc.  1.  Mast  cell-tumor cell  interaction.  Transmission electron  microscopy. Rat  mast cells  (M) 
were incubated with tumor cells  (T) in the standard salt solution (see Table I) for 30 rain at 37°(3. 
The mast cell  shown here contains the typical membrane-bound granules (G) of an unstimulated 
mast cell.  Tumor cells  with numerous surface microvilli were of normal appearance, unchanged 
from cells  incubated in standard salt solution without mast cells. (3ytoplasmic lipid inclusions (L) 
were seen in some tumor cells.  ×  11,750. 
FIG.  2.  Effect  of 48/80  on  mast  cell-tumor cell  interaction.  Transmission electron  microscopy. 
Mast cells  (M) were incubated with tumor cells  in the standard salt solution (Table I) containing 
1.0 #g/ml compound 48/80  for 30  min at  37°(3.  Noncytotoxic degranulation  of mast cells  was 
evident with the formation of channels ((3) containing swollen granules which had lost their electron 
density (arrows). The adjacent tumor cell  (T) shows no evidence of cytotoxic damage. ×  11,750. Flo.  3.  Effect  of H202  and  iodide  on  mast  cell-tumor  cell  interaction.  Transmission electron 
microscopy. Mast ceils were incubated with tumor cells  in standard salt solution containing H202 
(10  -4 M) and iodide (10 -4 M) for 30 min at 37°C as described in Table I. (a) Mast cells (M) showed 
extensive degranulation;  their cytoplasm, cytoplasmic organelles and surface structure remained 
otherwise intact.  Portion of a  tumor cell  (T)  exhibiting cytolytic changes is shown. ×  11,500.  (b) 
The cytotoxic effect  of the mast cell-H202-iodide system is well  visualized in this tumor cell. There 
is nuclear pyknosis (N), aggregation and  dilatation  of the mitochondria (m), and  loss of surface 
microvilli.  ×  8,500.  (c) Secreted mast cell granules (G) were often noted to adhere to the tumor cell 
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Fro.  4.  Mast cell-tumor cell interaction. Scanning electron microscopy. Mast cells (M) and tumor 
cells  (T)  were  incubated  in  the  standard  salt  solution  as  in  Fig.  1.  The  mast  cells  show  the 
characteristic surface ridges of unstimulated mast cells. The tumor cells which are slightly smaller 
than the mast cells, have prominent surface microvilli and folds. ×  5,100. 
FxG.  5.  Effect of 48/80  on mast cell-tumor cell  interaction.  Scanning electron microscopy. Mast 
cells (M)  and tumor cells (T) were  incubated in  the standard salt solution containing compound 
48/80  as in  Fig.  2.  The mast cell contained fewer surface ridges, and  bulges were observed over 
submembranous granules which is typical of the degranulation process. MCG were adherent to the 
tumor cell surface (arrows) which was otherwise unchanged. ×  5,500. 
FIG.  6.  Effect of H~)2 and iodide on mast cell-tumor cell interaction. Scanning electron micros- 
copy.  Mast cells (M)  and tumor cells  (T)  were  incubated with H202 and iodide under the same 
conditions outlined in Fig. 3. Many extracellular granules are noted on the surface of mast cells and 
tumor cells,  and  the  tumor cell  surface showed striking cytotoxic  changes. There  was  a  loss of 
microvilli and membrane folds, and holes (arrows) in the surface membrane were noted. X  12,000. 
electron  microscopy  revealed  a  striking  disruption  of  the  tumor  cell  nuclear  and 
cytoplasmic  structure  with  aggregation  and  dilatation  of  mitochondria  and  loss  of 
cell-surface  microvilli  (Fig.  3).  Scanning  electron  microscopy  showed  a  loss  of  the 526  MAST CELL-MEDIATED TUMOR-CELL KILLING 
normal villous projections, alteration of cell shape, and formation of holes in the cell 
surface (Fig. 6). MCG were evident on the smooth tumor cell surface (Fig. 3c; Fig. 6). 
Tumor cells were unaffected by incubation with H202 and iodide in the absence of 
mast cells under our experimental conditions. Their appearance by either transmission 
or scanning electron microscopy was identical to tumor cells incubated in the standard 
salt solution alone or with mast cells in standard salt solution (Fig.  1; Fig. 4). Similarly, 
the tumor cells were morphologically intact when 1-/202 or iodide was omitted from 
the mast cell-H202-iodide system. 
H202-induced Mast Cell Secretion.  The mast cell secretion observed when mast cells 
are incubated with tumor cells, H202, and iodide  (Table I; Fig. 3a;  Fig. 6)  is due to 
the  added  H~D2.  Under  our experimental  conditions,  mast  cells  incubated  in  the 
standard salt solution with  10  -4 M  H~O2 alone for  1 h  released 45.3  ±  4.6%  (mean 
±  SE; n =  6)  of their histamine content  (background 8.5 ±  2.7%;  n =  6; P  <  0.001) 
without a  corresponding release above background of the cytoplasmic marker, LDH 
(4.1  -I- 2.1% compared with 3.6 ±  1.8% background release; n  =  6). Iodide (10  -4 M) 
plus tumor cells did not significantly increase histamine release from mast cells above 
background in the absence of H~O2 (9.3 ±  3.1%; n =  3), nor did they affect histamine 
release by  10  -4  M  H~O2  (50.1  ±  6.1%;  n  --  3).  As previously reported  (14),  lower 
concentrations of H~O~ (2  ×  10  -5 M)  did not induce mast cell degranulation  unless 
supplemented with EPO and a halide. 
The induction of noncytotoxic mast cell degranulation by H202 was confirmed by 
electron microscopy (Fig.  7). Mast cells incubated in the standard salt solution alone 
exhibited the usual morphology of unstimulated cells with numerous electron-dense, 
membrane-bound granules  (Fig.  7a). The surface view (Fig.  7b) revealed the typical 
ridges  and  villous  projections  of normal  mast  cells.  H202  (10  -4  M)  induced  the 
formation of vacuoles containing swollen and  less dense  granules  and  extracellular 
extrusion  of  the  altered  granules  (Fig.  7c).  The  reduction  in  surface  ridges,  the 
formation of bulges on  the cell  surface, and  the  extrusion  of granules  revealed  by 
scanning electron microscopy were characteristic of mast cell secretion (Fig.  7d).  No 
concomitant cell damage was evident. 
MCG-mediated Tumoricidal Activity.  The degranulation  of mast cells by H202 and 
the associated damage to tumor cells on the addition of iodide raised the possibility 
that the MCG was the mast cell component required  for toxicity. This is supported 
by the  data  shown  in  Table  I.  Incubation  of 51Cr-labeled  tumor cells  with  MCG, 
iodide  (10  -4 M), and H202  (10  -4 M)  increased 5XCr release from a  background  19.9 
to 61.9%  (P <  0.001).  This cytotoxic effect was abolished by omission of any MCG- 
H202-iodide system components, by heat inactivation of MCG, and by the hemepro- 
tein  inhibitors  azide and  aminotriazole.  Cyanide  (10  -3 M)  decreased  (P <  0.05  vs. 
complete system) but did not abolish (P <  0.01  vs. background) activity. 
When  MCG were incubated  with  the  tumor cells without  H202 and  iodide,  the 
granules  adhered  to  the  surface of the  cells  but  no  cytotoxic  effect  was  noted  by 
scanning  electron  microscopy  (Fig.  8).  The  further  addition  of H202  and  iodide, 
however, resulted  in  extensive damage  (Fig.  9)  comparable to that  observed when 
intact mast cells were employed (Fig. 6). 
Effect of EPO on MCG-induced Toxicity.  EPO is cytotoxic to the LSTRA tumor cell 
line when combined with H20~ and iodide (9), and this enzyme forms a firm complex 
with MCG with retention of peroxidatic activity (11). Table II compares the cytotoxic W.  R.  HENDERSON,  E.  Y.  CHI,  E.  C.  JONG,  AND  S.  J.  KLEBANOFF  527 
Fxc.  7.  H2Ch-induced mast cell secretion. Mast cells were incubated in the standard salt solution 
without  (a,b)  or with  (c,d)  added H202  (10  -4 M)  for 30 min at  37°(3.  (a)  Transmission electron 
microscopy shows a  typical  unstimulated  mast  cell  with  its  many electron-dense  granules and 
prominent microridges evenly distributed over the surface membrane. X  10,500.  (b) The predomi- 
nant surface microridges were evident by scanning electron microscopy. ×  11,500.  (c) Noncytotoxic 
mast cell degranulation was seen by transmission electron microscopy with the typical formation of 
channels  (C)  containing swollen  granules.  X  8,500.  (d)  Scanning electron  microscopy  revealed 
surface structure typical of mast cell degranulation. Pores were open to the outside of the cells and 
extracellular granules (G) were seen on the cell surface and within the pores (arrows). Surface bulges 
and the loss of most of the microridges were noted. ×  10,500. 528  MAST  CELL-MEDIATED  TUMOR-CELL  KILLING 
FIG. 8.  Effect of MCG on tumor cells. MCG  were incubated with  tumor cells in  buffered salt 
solution (see Table I) for 30 min at 37°C. The granules attached to the tumor cell surface (arrows) 
but no cytotoxic damage to the tumor cells was noted by scanning electron microscopy. ×  6,500. 
Fro.  9.  Effect of MCG-H202-iodide system on tumor cells. MCG were incubated with tumor cells 
in  buffered salt  solution  containing  H~2  (10 -4  M)  and  iodide  (10  -4  M)  for  30  rain  at  37°C. 
Scanning electron microscopy showed that the tumor cell surface structure was greatly altered with 
loss of microridges, changes in cell shape, and holes in the cell membrane. MCG were adherent to 
the tumor cell surface (arrows). ×  8,500. 
TABLE  II 
Comparison of the Cytotoxic Activity of the MCG and MCG-EPO Systems* 
Protein 
SlCr release 
MCG  MCG-EPO  Pa  4 
#g  % 
0.2  29.5  ±  3.1§  59.3  ±  4.8  <0.002 
2.0  39.8  :t: 3.4  84.9 ±  5.5  <0.002 
8.0  59.6 ±  5.4  89.7  :t: 3.5  <0.02 
20.0  77.1 :t: 5.2  92.3 -t- 4.9 
* The reaction mixture was as described for the MCG system in Table I except 
that the amount of MCG or MCG-EPO complexes was varied as indicated. 
The peroxidase activity of the MCG was 0.02 mU/#g protein and that of the 
MCG-EPO complex was 0.20-0.23 mU/#g protein. Background 51Cr release 
(without MCG, MCG-EPO, H202, or iodide) was 22.1  +  3.5%. 
:]: Probability  values  for  the  difference between  the  MCG  and  MCG-EPO 
systems, where significant (P <  0.05). 
§ Mean +  SE of five experiments. 
activity  of the  MCG-EPO  complex  to  that  of MCG,  standardized  to equal  granule- 
protein  concentrations.  In  the  0.2-8.0  #g  granule-protein  range,  51Cr  release  was 
significantly  increased  when  EPO  was  bound  to  the  granules  under  the  conditions 
employed.  This  difference  was  lost  when  the  granule  concentration  was  increased  to 
20 pg protein.  The  MCG-EPO  complex  was also more  effective as a  component  of the 
peroxidase  system  than  was  free EPO  over a  range  of peroxidase  activity  from  0.1  to W.  R.  HENDERSON,  E.  Y.  CHI,  E.  C. JONG,  AND  S. J.  KLEBANOFF 
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Fro.  10.  Comparison of the cytotoxic activity of the MCG-EPO complex and EPO systems. The 
reaction  mixture was as described for the MCG system in  Table  I  except that  the MCG  were 
replaced by EPO (O)  or MCG-EPO complexes (91) at the indicated peroxidase activity. The data 
are the mean =l= SE of five experiments and the probability values for the difference between the 
EPO and MCG-EPO systems are shown where significant (P <  0.05). 
TABLE  III 
Effect of Halide Concentration on MCG-EPO-induced Cytotoxicity* 
529 
Supplements 
SlCr release 
pH 7.0  pH 6.0 
%  P  %  P 
Background  19.5 ±  2.8 (5)$  21.3  ±  1.6 (5) 
MCG-EPO +  I- (10 -4 M) +  HaO2  89.8 ±  5.1  (3)  <0.001  95.3 ±  4.0 (3)  <0.001 
MCG-EPO +  I- (10 -5 M) +  H~)2  60.6 ±  4.5 (4)  <0.001  75.3 ±  6.1  (3)  <0.001 
MCG-EPO +  I- (10 -6 M) +  H202  23.4 ±  3.9 (4)  64.5:1:5.2  (4)  <0.001 
MCG-EPO +  I- (10 -7 M) +  H,~O2  24.2 ±  3.0 (4)  28.3  ±  2.3 (4)  <0.05 
MCG-EPO +  I- (10 -s M) +  H202  22.8  ±  2.8 (3)  20.1  ±  3.6 (3) 
MCG-EPO +  BR- (10 -4 M) +  H~2  82.7 ±  3.9 (4)  <0.001  89.8 ±  5.1  (4)  <0.001 
MCG-EPO +  BR- (10 -5 M) +  H~O2  54.8 ±  4.2 (3)  <0.001  64.7  ±  8.1  (3)  <0.001 
MCG-EPO +  BR- (10 -s M) +  HzO~  35.3 ±  5.2 (3)  <0.05  45.7 ±  7.5 (3)  <0.01 
MCG-EPO +  BR- (10  -7 M) +  H202  25.2  ±  3.7 (4)  32.4 ±  4.1  (4)  <0.05 
MCG-EPO +  BR- (10 -8 M) +  H202  21.9 ±  1.9 (4)  21.5 ±  2.3 (4) 
MCG-EPO +  CI- (10 -1 M) +  H20~  23.0 ±  2.7 (4)  42.0 ±  4.8 (4)  <0.01 
* The reaction mixture was as described for MCG  in  Table  I  except that  the MCG were replaced by 
MCG-EPO complexes (6/xg protein;  1.2-1.4 mU peroxidase activity) and the concentration of halide 
was varied as indicated. Probability values for the difference from background are shown where significant 
(P <  0.05). 
:1: Mean ±  SE of experiments (n). 
4  mU  guaiacol  (Fig.  10).  This  difference  was  abolished  with  a  further  increase  in 
peroxidase  activity. 
The  MCG-EPO  complex-H2Oz-halide  system was cytotoxic  to the LSTRA  cells at 
iodide  concentrations  of  10 -4  and  10 -~  M  at  pH  7.0,  and  10-4-10 -7  M  at  pH  6.0 530  MAST  CELL-MEDIATED  TUMOR-CELL  KILLING 
(Table III). Bromide was effective from  10  -4 to  10  -6 M  at pH 7.0, and down to  10  -7 
M  at pH 6.0. Chloride at 0.1  M  was ineffective at pH 7.0, but could meet the halide 
requirement  at  pH  6.0.  A  2.5  M  solution  of the  NaCI employed was  sent  to  Bio- 
Science Laboratories, Van Nuys, Calif.,  for assay of iodide and  bromide.  The total 
iodine was designated as  "none detected."  Because the assay employed can readily 
detect 0.1 #g/100 ml of iodide, this would indicate that the iodide contribution by the 
0.1 M  NaCI solution was <5 ×  10  -~° M  or well below that which was toxic under the 
conditions  employed  in  Table  III.  No  bromide  was  detected  in  the  2.5  M  NaC1 
solution.  However the  limit  of the  bromide  assay was  0.1  rag/100  ml  so  that  the 
bromide concentration contributed by the 0.1  M  NaCI, although unknown, may be 
up tO 5 ×  10 -7 M. Bromide is toxic at pH 6.0 at concentrations down to  1 ×  10  -7 M 
(Table III); therefore our data does not exclude the possibility that the chloride effect 
is due partially or totally to bromide contamination. 
Discussion 
We report  here that  mast  cells  are  toxic to  LSTRA tumor cells  when combined 
with H202 and iodide. Our studies suggest the following sequence of events: H202 in 
the concentration used in the tumoricidal system (10 -4 M) initiates noncytotoxic mast 
cell secretion; MCG contain a small amount of endogenous peroxidase (10); the MCG 
peroxidase  reacts with  H202 and  iodide to kill  the  tumor cells.  Thus  H20~ would 
serve here both to induce mast cell secretion and as a component of the MCG-H202- 
iodide cytotoxic system. Evidence in support of this sequence is as follows: 
H202  at  10  -4  M  induces  mast  cell  secretion  (as  measured  by histamine  release) 
without associated cell lysis  (as measured by LDH release).  The initiation of noncy- 
totoxic mast cell degranulation by H202  is supported by ultrastructural studies  (Fig. 
7). Transmission electron microscopy revealed many swollen granules with decreased 
density in vacuoles and channels, some open to the outside of the cell;  extracellular 
granules  were seen  by both  transmission  and  scanning electron  microscopy. There 
was no evidence of mast cell damage. This effect of H20~ confirms the earlier findings 
ofOhmori et al.  (12,  13) who reported that xanthine oxidase when incubated with its 
substrate,  hypoxanthine,  induced  noncytotoxic histamine  release  from  mast  cells. 
Histamine release by this oxygen radical- and HzO2-generating system was inhibited 
by catalase but was unaffected by either the superoxide anion scavenger, superoxide 
dismutase, or the hydroxyl radical scavenger, mannitol, suggesting a  role for H202. 
They also reported that H202 alone could initiate mast cell degranulation at concen- 
trations of 5 ×  10  -5 M  or greater (12,  13). 
Isolated MCG when combined with H202 and iodide are toxic to the tumor cells, 
as measured by 5~Cr release and confirmed by electron microscopy. The properties of 
the mast cell- and MCG-mediated systems were comparable: each component of the 
systems (mast cells  or MCG, H202, iodide)  was required, and cytotoxic activity was 
abolished  by  the  addition  of the  peroxidase  inhibitors  azide  and  aminotriazole. 
Cyanide was only partially inhibitory of the MCG system and did not affect the intact 
mast cell system under our experimental conditions. The relative insensitivity of the 
MCG peroxidase  to cyanide was similar  to the response of EPO  to cyanide under 
comparable experimental conditions (9,  15). MCG were seen by electron microscopy 
to adhere to the surface of LSTRA tumor cells but cytotoxic damage (severe  nuclear 
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membrane) was induced only when H202 and iodide were added (Figs. 3, 5, 6, 8, and 
9). Although  our studies were performed only with mast cells, basophils, the blood- 
borne leukocytes with many properties similar to those of tissue mast cells, may react 
similarly.  In  an  ultrastructural  study  of the  immunologic  rejection  of syngeneic, 
chemically induced  tumors implanted intradermally in previously sensitized guinea 
pigs (17), basophils were observed to be in close contact with both living and dead 
tumor cells and to degranulate.  In vitro studies  (18)  indicated that basophils stimu- 
lated to degranulate either by antigen or lectin could exert a  modest cytotoxic effect 
when cultured for 1-24 h with the tumor cells (< 10% of tumor cells affected). Isolated 
basophil granules were observed to adhere to the tumor cell surface (18) with minimal 
or no damage resulting from this interaction. This is analogous to the attachment of 
unsupplemented  MCG  to  the  tumor cell  surface  in  our studies.  In  our  mast  cell- 
mediated tumoricidal system, H202 and iodide were necessary for toxic activity, and 
it  is not  known  whether  these  substances were  required  for the  basophil-mediated 
damage. 
Eosinophils  may influence  mast  cell  tumoricidal  activity  in  a  number  of ways. 
Eosinophils in common with other phagocytes form and release H202 on appropriate 
stimulation (19-21) and thus could supply this needed component of the tumoricidal 
system.  Degranulation  of eosinophils  can  occur  with  the  release  of their  granule 
peroxidase (22,  23).  Although as reported here and by Ohmori et al.  (12,  13),  H202 
alone can  cause  noncytotoxic mast cell  secretion,  when  the  H202  concentration  is 
reduced to a  level where it is no longer effective in this regard, the addition of EPO 
and  iodide  leads  to  a  return  in  secretory activity  (14).  EPO,  a  positively charged 
protein, binds tightly to the secreted histamine-free MCG, forming a stable complex 
which dissociates only when suspended in hypertonic salt solutions (0.75 M or greater) 
(11). The MCG-EPO complex-HzO2-iodide system has significantly greater bacteri- 
cidal  and  iodinating  activity  than  the  granule-free  EPO  system  when  the  two 
preparations are standardized to equal guaiacol units of peroxidase activity (11).  We 
report here that when combined with H202 and iodide, the MCG-EPO complex has 
greater tumoricidal activity than does either an equivalent weight of MCG without 
bound EPO or an equivalent amount of free EPO (as measured by guaiacol oxidation). 
At pH 7.0,  iodide was effective at  10  -4 and  10  -5 M  and bromide at  10  -4 to  l0 -6 M; 
whereas at pH 6.0, significant cytotoxic activity as measured by 51Cr release was seen 
at iodide or bromide concentrations down to l0  -7 M. Chloride at  10  -1 M  could meet 
the halide requirement at pH 6.0 but not at pH 7.0. 
These findings suggest that the following sequence of events could occur at tumor 
sites characterized by an eosinophil and mast cell response. Eosinophils attracted to 
the  inflammatory  site  may  be  activated  there  with  the  secretion  of EPO.  H202 
generated by the stimulated eosinophils or by other phagocytes in the region would 
be expected and  the  H202  either alone or combined with  EPO  and  a  halide  may 
initiate  mast  cell  secretion.  The  release  of the  chemical  mediators  of immediate 
hypersensitivity, together with  the  formation of stable  MCG-EPO  complexes with 
potentiated  cytotoxic activity may then  contribute  to  the  host  defense against  the 
neoplastic cells. 
Summary 
Mast cells, when supplemented with H202 and iodide, are cytotoxic to mammalian 
tumor cells as  determined  by 51Cr release, and  transmission  and  scanning electron 532  MAST CELL-MEDIATED  TUMOR-CELL KILLING 
microscopy, H20~ at the concentration employed (10 -4 M) initiates mast cell degran- 
ulation, and mast cell granules (MCG), which contain a small amount of endogenous 
peroxidase  activity, are toxic to tumor cells when combined with  H202 and  iodide. 
This toxicity is greatly increased by binding eosinophil peroxidase (EPO) to the MCG 
surface. Each component of the mast cell, MCG, or MCG-EPO system was required 
and  toxicity  was  inhibited  by the  addition  of the  hemeprotein  inhibitors  azide  or 
aminotriazole, which is compatible with a requirement for peroxidase in the cytotoxic 
reaction. A sequence of reactions is proposed in which mast cells, stimulated to release 
their  granules  by H202  generated  by adjacent  phagocytes,  react  with  H202  and  a 
halide  to damage tumor cells.  EPO release  from eosinophils may contribute  to this 
sequence of reactions,  both  by stimulation  of H202-induced  mast cell secretion and 
by combination with MCG to form a complex with augmented tumoricidal activity. 
These reactions may play a  role in the host defense against neoplasms. 
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